These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35324372)

  • 1. The cross-talk between mucormycosis, steroids and diabetes mellitus amidst the global contagion of COVID-19.
    Dwivedi S; Choudhary P; Gupta A; Singh S
    Crit Rev Microbiol; 2023 May; 49(3):318-333. PubMed ID: 35324372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Black fungus immunosuppressive epidemic with Covid-19 associated mucormycosis (zygomycosis): a clinical and diagnostic perspective from India.
    Singh K; Kumar S; Shastri S; Sudershan A; Mansotra V
    Immunogenetics; 2022 Apr; 74(2):197-206. PubMed ID: 34596728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
    Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
    J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 associated mucormycosis - An emerging threat.
    Chao CM; Lai CC; Yu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and mucormycosis superinfection: the perfect storm.
    Al-Tawfiq JA; Alhumaid S; Alshukairi AN; Temsah MH; Barry M; Al Mutair A; Rabaan AA; Al-Omari A; Tirupathi R; AlQahtani M; AlBahrani S; Dhama K
    Infection; 2021 Oct; 49(5):833-853. PubMed ID: 34302291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications.
    Gurunathan S; Lee AR; Kim JH
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COVID-19 associated mucormycosis. A case in Argentina].
    Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
    Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
    Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
    Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Responses and CNS Pathophysiology of Mucormycosis in Chronic SARS Cov-2 Infection: Current Therapies Against Mucormycosis.
    Beeraka NM; Liu J; Sukocheva O; Sinelnikov MY; Fan R
    Curr Med Chem; 2022; 29(32):5348-5357. PubMed ID: 35538800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucormycosis and Its Upsurge During COVID-19 Epidemic: An Updated Review.
    Sharma B; Nonzom S
    Curr Microbiol; 2023 Aug; 80(10):322. PubMed ID: 37592083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucor in a Viral Land: A Tale of Two Pathogens.
    Sen M; Lahane S; Lahane TP; Parekh R; Honavar SG
    Indian J Ophthalmol; 2021 Feb; 69(2):244-252. PubMed ID: 33463566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID Induced Functional Exhaustion and Persistently Reduced Lymphocytes as Vital Contributing Factors for Post-COVID Rhino-orbital and Cerebral Mucormycosis in Patients with Diabetes: Report from the Indian Sub-continent.
    Bhargava D; Ahirwal R; Dubey S; Gurjar P; Pandey A; Beena S; Koneru G
    Head Neck Pathol; 2022 Sep; 16(3):645-650. PubMed ID: 34751896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis, The Deadly New Worry to COVID-19 Pandemic.
    Kamrul-Hasan AB; Selim S
    Mymensingh Med J; 2021 Jul; 30(3):874-880. PubMed ID: 34226483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-Associated Mucormycosis: An Opportunistic Fungal Infection. A Case Series and Review.
    Balushi AA; Ajmi AA; Sinani QA; Menon V; Berieki ZA; Shezawi AA; Azri SA; Rashdi AA; Jardani AA; Baluki TA; Ghaithi SA; Reesi AA; Al-Za'abi AT; Al' Balushi MA; Maqbali TA
    Int J Infect Dis; 2022 Aug; 121():203-210. PubMed ID: 35533833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.
    Azhar A; Khan WH; Khan PA; Alhosaini K; Owais M; Ahmad A
    J Infect Public Health; 2022 Apr; 15(4):466-479. PubMed ID: 35216920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucormycosis in the COVID-19 Environment: A Multifaceted Complication.
    Sharma R; Kumar P; Rauf A; Chaudhary A; Prajapati PK; Emran TB; Gonçalves Lima CM; Conte-Junior CA
    Front Cell Infect Microbiol; 2022; 12():937481. PubMed ID: 35923801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on SARS-CoV-2-associated fungal coinfections.
    Soni S; Namdeo Pudake R; Jain U; Chauhan N
    J Med Virol; 2022 Jan; 94(1):99-109. PubMed ID: 34570905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
    Singh AK; Singh R; Joshi SR; Misra A
    Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.
    Sharma S; Grover M; Bhargava S; Samdani S; Kataria T
    J Laryngol Otol; 2021 May; 135(5):442-447. PubMed ID: 33827722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.